Pfizer settles Protonix patent case for $2.15B
Two generic drugmakers will pay $2.15 billion to Pfizer and Takeda Pharmaceutical to settle a patent fight over the heartburn treatment Protonix.
Jun 12, 2013
not rated yet |
0
not rated yet |
0
